First patient receives age-reversal therapy in historic human trial Boston-based Life Biosciences has dosed the first participant with ER-100, an experimental therapy designed to reverse aspects of cellular aging and treat vision loss
Delen
25 articles on page 1
23 september
20 september
06 september
02 september
30 augustus
23 augustus
15 augustus
12 augustus
06 augustus
28 juli
27 juli
23 juli
05 juli
25 juni
23 juni
Spørgsmål om ungdom, lang levetid og kropsfornyelse. Forskning i gerontologi, nye videnskabelige synspunkter på forventet levetid.